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Abstract
Objective This study aimed to investigate the association between BMI at 65 years of age and the develop-
ment of hypertension during the subsequent five years.
Methods A total of 1,003 participants (65 years of age) who had no history of myocardial infarction and/or
hypertension at baseline health check-ups (1996-2005) and participated in a secondary health check-up when
the subjects reached 70 years of age were analyzed.
Results Using fully adjusted models, men with a BMI of <18.5 [odds ratio (OR), 4.08; 95% confidence in-
terval (CI), 1.32-1.83], BMI of 23.0-24.9 (OR, 2.00; 95% CI, 1.18-3.40) and BMI of 25.0 (OR, 1.98; 95%
CI, 1.10-3.56) were found to be at higher risk of developing hypertension than did those with a BMI of 18.5-
22.9.
Conclusion Leanness or being overweight/obese at age 65 increases the risk of subsequent hypertension.
Key words: hypertension, overweight, obesity, elderly, body mass index
(Intern Med 54: 3121-3125, 2015)
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Introduction
Hypertension is the strongest and most well established
risk factor for stroke (1) and cardiovascular disease (2, 3)
and is the leading cause of death worldwide (4). Approxi-
mately one-half (51.8%) of all Japanese elderly people have
hypertension (5), and 25.8% of individuals with hyperten-
sion are overweight/obese, defined as a body mass index
(BMI) of 25.0 kg/m2 (5); this proportion continues to in-
crease. Previous studies have indicated that being over-
weight/obese (6-19) increases the risk of hypertension in
general.
Most Japanese employees retire from their jobs between
60 and 65 years of age; this leads to a big change in their
lifestyles. In addition, the death rate accelerates after 65
years of age (20), even in Japan, a country with the highest
rate of longevity (21). However, few epidemiological studies
have focused on younger elderly people.
This study aimed to investigate the association between
BMI at 65 years of age and the development of hyperten-
sion during the subsequent five years in an age-specified co-




The protocol for the NISSIN study has been described in
detail previously (22). In brief, the participants included
3,073 residents (1,548 men and 1,525 women) from Nisshin
city, Japan who were approaching 65 years of age at base-
line and attended a health check-up in June during the pe-
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Table　1.　Characteristics of the Study Participants at Baseline According to Body Mass Index.
Body mass index
Male Female
<18.5 18.5–22.9 23.0–24.9 5.0 p value <18.5 18.5–22.9 23.0–24.9 5.0 p value
Participants who took secondary health
check-up
n=18 n=220 n=134 n=88 n=39 n=321 n=110 n=73












125.3 ± 9.3 125.0 ±
10.3 <0.001
Diastolic blood pressure (mmHg) 73.1 ± 9.0 75.2 ± 6.8 76.2 ± 7.4 78.0 ± 6.6 0.003 70.7 ± 8.6 72.0 ± 7.2 74.1 ± 6.9 74.5 ± 6.2 0.001
Current smoker (%) 12 (66.7) 76 (34.6) 35 (26.1) 21 (23.6) 0.001 2 (5.1) 8 (2.5) 3 (2.7) 3 (4.1) 0.74
Current alcohol drinker (%) 13 (72.2) 154 (70.0) 93 (69.4) 59 (66.3) 0.91 6 (15.4) 76 (33.0) 24 (21.8) 11 (15.1) 0.32
Regular exerciser (%) 10 (55.6) 81 (36.8) 35 (26.1) 36 (40.5) 0.02 16 (41.0) 119 (37.0) 48 (43.6) 30 (41.1) 0.63
Lipids (mean ± s.d, mg/dL)

















HDL-C 62.8 ± 17.8 53.9 ± 1,305 49.6 ± 11.4 48.7 ±
11.7
<0.001 70.0 ± 17.1 62.7 ± 14.4 57.6 ± 11.0 55.9 ± 12.9 <0.001













Fasting blood glucose (mean ± s.d, mg/dL) 103.5 ±
32.5




0.01 92.2 ± 8.4 94.3 ± 14.2 98.9 ± 16.8 101.5 ±
27.8
<0.001
Hemoglobin A1c (mean ± s.d, %) 5.8 ± 1.2 5.4 ± 0.8 5.6 ± 0.9 5.5 ± 0.8 0.18 5.1 ± 0.4 5.3 ± 0.5 5.6 ± 0.8 5.6 ± 0.9 <0.001
Undergoing treatment for hyperlipidemia (%) 1 (5.6) 8 (3.6) 6 (4.5) 6 (6.7) 0.54 1 (2.6) 17 (5.3) 18 (16.4) 4 (5.5) 0.002
Undergoing treatment for hyperglycemia (%) 4 (22.2) 9 (4.1) 8 (6.0) 6 (6.7) 0.04 0 (0) 4 (1.2) 5 (4.6) 2 (2.7) 0.14
Family history of hypertension (%) 2 (11.1) 13 (6.0) 4 (3.0) 5 (5.6) 0.41 3 (7.7) 25 (7.8) 5 (4.6) 7 (9.6) 0.59
p values were calculated by the analysis of variance, Ȥ 2 test, or Fisher’s exact test.
Values are expressed as mean ± standard deviation or numbers (percentage).
riod of 1996 through 2005 (response rate, 43.9%). Patients
with myocardial infarction and/or hypertension at baseline
were excluded.
Data collection
The health check-up included measurements of height and
weight, systolic blood pressure (SBP) and diastolic blood
pressure (DBP) and laboratory blood testing, such as assess-
ments of serum lipids and glucose. All clinical tests were
performed at a single laboratory. Blood pressure was meas-
ured using a standard mercury sphygmomanometer on the
right arm in the sitting position. BMI was calculated as
weight (kg) divided by height (m) squared. Four categories
of BMI (<18.5, 18.5-22.9, 23.0-24.9 and 25.0) were cre-
ated (23). Hyperlipidemia was defined as a total cholesterol
level of 240 mg/dL or the self-reported use of medications
for hyperlipidemia, and hyperglycemia was defined as a
fasting blood glucose level of 126 mg/dL, hemoglobin A1c
(HbA1c) level of 6.5% or the self-reported use of medica-
tions for hyperglycemia. The HbA1c levels were converted
from the format of the Japan Diabetes Society (JDS) to the
National Glycohemoglobin Standardization Program [NGSP:
NGSP (%) =1.02× JDS (%) + 0.25 (%)]. Demographic and
lifestyle characteristics, such as smoking, alcohol consump-
tion, medication use and family history of hypertension,
were also collected using a baseline self-administered ques-
tionnaire.
All participants provided their informed consent to par-
ticipate in the current study at the site of the health check-
up. Oral consent for the questionnaire survey and use of test
results from the health check-up was obtained using an opt-
out approach until 2001, and written consent was obtained
via an opt-in approach thereafter (24). The study protocol
was approved by the Ethics Committee of Nagoya Univer-
sity Graduate School of Medicine, National Center for Geri-
atrics and Gerontology of Japan, Aichi Medical University
School of Medicine and Hokkaido University Graduate
School of Medicine.
Follow-up
The prevalence of hypertension was ascertained at the
secondary health check-up at the same site of the June
check-up when the participants reached 70 years of age. Hy-
pertension was defined as SBP 140 mmHg and/or DBP
90 mmHg and/or self-reported medication treatment for hy-
pertension.
Statistical analysis
Of the 3,073 original cohort members, 1,406 participants
with a history of myocardial infarction and/or hypertension
at baseline and 116 and 75 participants who died or moved
from the study area, respectively, were excluded. Another
473 participants who did not undergo the secondary health
check-up were also excluded. Finally, data for 1,003 partici-
pants (460 men and 543 women) were analyzed in the pres-
ent study (Table 1). An analysis of variance or the χ2 test
was used to analyze the associations of BMI with the par-
ticipant characteristics. Multivariate odds ratios (ORs) and
95% confidence intervals (95% CIs) of the BMI at baseline
for the development of hypertension at 70 years of age were
calculated using logistic regression models and adjusted for
potential confounders, such as the survey year, baseline SBP
(continuous), current smoking (yes, no/unknown), current al-
cohol drinking (yes, no/unknown), regular exercise (yes, no/
unknown), hyperlipidemia (yes, no/unknown), hyperglyce-
mia (yes, no/unknown) and family history of hypertension
(yes, no/unknown). In the additional analyses, participants
who developed isolated systolic hypertension (ISH: SBP
140 mmHg, DBP <90 mmHg and no use of antihyperten-
sive medications) (25) were compared with the normoten-
sive (SBP <140 mmHg, DBP <90 mmHg and no antihyper-
tensive medications) participants. An alpha level of 0.05 was
considered to be statistically significant. All statistical analy-
ses were performed using the SAS version 9.4 software pro-
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Table　2.　Odds Ratios for Newly Hypertension at Age of 70 Years According to Baseline Body Mass Index.
Body mass index(kg/m2)
<18.5 18.5–23.0 23.0–24.9 5.0
Male
No. of participants 18 220 134 88
No. of cases (No. of medication for hypertension) 8(3) 49(16) 45(22) 33(17)
Model 1 OR (95%CI) 3.48 (1.23–9.84)* ref 1.96 (1.19–3.23)* 2.11 (1.20–3.68)*
Model 2 OR (95%CI) 4.08 (1.32–12.4)* ref 2.00 (1.18–3.40)* 1.98 (1.10–3.56)*
Female
No. of participants 39 321 110 73
No. of cases (No. of medication for hypertension) 8(1) 78(35) 36(14) 26(12)
Model 1 OR (95%CI) 0.73 (0.32–1.71) ref 1.46 (0.90–2.36) 1.74 (0.99–3.05)
Model 2 OR (95%CI) 0.75 (0.31–1.83) ref 0.93 (0.55–1.59) 1.39 (0.76–2.54)
Isolated systolic hypertension
Male
No. of participants 13 182 108 66
No. of cases 5 38 26 23
Model 1 OR (95%CI) 2.47 (0.78–7.81) ref 1.27 (0.72–2.23) 1.77 (0.96–3.27)
Model 2 OR (95%CI) 2.98 (0.87–10.2) ref 1.27 (0.70–2.32) 1.73 (0.90–3.31)
Female
No. of participants 32 271 83 55
No. of cases 7 51 27 18
Model 1 OR (95%CI) 1.02 (0.40–2.55) ref 1.73 (0.99–3.01) 1.78 (0.94–3.40)
Model 2 OR (95%CI) 1.05 (0.41–2.74) ref 1.22 (0.67–2.23) 1.49 (0.76–2.94)
OR: odds ratio, CI: confidence interval. p < 0.05.
aORs for developing isolated systolic hypertension (systolic blood pressure 140 mmHg, diastolic blood pressure <90, and no antihypertensive 
medication) compared with normal blood pressure (systolic blood pressure <140 mmHg, diastolic blood pressure <90 mmHg, and no
antihypertensive medication).
Model 1: adjusted for survey year.
Model 2: adjusted for survey year, systolic blood pressure (as continuous), current smoking (yes/no), current alcohol drinking (yes, 
no/unknown), regular exercising (yes, no/unknown), hyperlipidemia (yes, no/unknown), hyperglycemia(yes, no/unknown), and family history 
of hypertension (yes, no/unknown).
Hyperlipidemia was defined as total cholesteURO240 mg/dL or self-reported medication for hyperlipidemia, and hyperglycemia was defined as 
fasting blood glXFRVH126 mg/dL or hemoglobin A1c 6.5% or self-reported medication for hyperglycemia.
gram (SAS Institute, Cary, USA).
Results
At 70 years of age, 283 participants (135 men and 148
women) had developed hypertension. Of these subjects, 195
(92 men and 103 women) had isolated systolic hypertension.
Table 1 shows the characteristics of the study participants
at baseline according to BMI. Among the male participants,
the group with a higher BMI demonstrated higher SBP,
DBP, total cholesterol, triglyceride and fasting blood glucose
levels and lower HDL-C levels and included fewer current
smokers and regular exercisers than did the group with a
lower BMI. Among the female participants, those with a
higher BMI showed higher triglyceride, fasting blood glu-
cose and HbA1c levels and lower HDL-C levels than did
the group with lower BMIs.
Table 2 shows the ORs for new hypertension at 70 years
of age according to the baseline BMI. After adjusting for
possible confounding factors, the ORs for the male partici-
pants with a BMI of <18.5, 23.0-24.9 and 25.0 were 4.08
(95% CI, 1.32-12.4), 2.00 (95% CI, 1.18-3.40) and 1.98
(95% CI, 1.10-3.56), respectively, while those for women
with a BMI of 23.0-24.9 and 25.0 were 0.93 (95% CI,
0.55-1.59) and 1.39 (95% CI, 0.76-2.54), respectively, when
compared to the participants with a BMI of 18.5-22.9. Simi-
lar associations were found for newly-developed isolated
systolic hypertension, although they did not reach statistical
significance.
Because the ratio of current smokers among lean men
was high (66.7%), these subjects might have given up smok-
ing, and the subsequent body weight gain might have led to
an elevated blood pressure. Therefore we conducted an addi-
tional analysis using the change in weight during the five-
year study period. The following categories for weight
changes were evaluated (-1 kg/m2, >-1 to 1 kg/m2, >1 to
2.9 kg/m2, 2.9 kg/m2) (26); however, there were no sig-
nificant associations between the change in weight and the
new onset of hypertension. In addition, there were no sig-
nificant associations between the categories of BMI at base-
line and the change in weight (data not shown).
Discussion
The current findings showed that both being underweight
and overweight/obese increased the risk of developing hy-
pertension among younger elderly men.
Several interventional studies have reported that treating
patients with hypertension using antihypertensive drugs re-
duces the risk of developing stroke, coronary heart disease
and heart failure (27-29). However, the use of these antihy-
pertensive treatments has a great burden on the Japanese
health insurance system, as the annual medical cost of treat-
ing hypertension in Japan is ¥1,830 billion (30) and contin-
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ues to increase. Because 51.8% of Japanese elderly people
are treated for hypertension (5), preventing hypertension is
therefore a matter of social importance.
Our findings are compatible with those of many previous
studies across various cohorts reporting that being over-
weight/obese increases the risk of developing hyperten-
sion (6-19). The biological mechanisms involved in the de-
velopment of hypertension associated with hyperadiposity
have not been fully elucidated. However, previous studies
have found associations of obesity with insulin resis-
tance (31), hyperinsulinemia (32), enhanced sympathetic
nervous system activity (33) and activation of the renin-
angiotensin-aldosterone system (34), all of which are in-
volved in the development of hypertension. In addition, en-
hanced salt sensitivity, which increases the blood volume,
has been found among obese subjects (35).
ISH is characterized by increased SBP without an in-
crease in DBP (36). The prevalence of ISH rises rapidly af-
ter 60 years of age in the Japanese population (37), and ISH
reportedly increases the risk of stroke (38) and cardiovascu-
lar disease (39, 40) in elderly people, even in older elderly
patients, among whom the mean age of ISH onset is around
70 years (37). The results of the present study showed that a
BMI of >25 nonsignificantly increases the likelihood of de-
veloping ISH. Therefore, maintaining a normal BMI may be
one of the most important issues for preventing hypertension
and subsequent stroke and cardiovascular disease.
The present study also demonstrated that a low body
weight (i.e., BMI <18) markedly increases the risk of devel-
oping hypertension among men. The mechanisms of this as-
sociation are unclear. However, previous studies have re-
ported that an increased BMI and latent adiposity, such as
that associated with a relatively increased fat mass and de-
creased fat-free mass, are associated with mortality (41). Ad-
ditionally, persons with a low BMI and elevated waist cir-
cumference have an increased risk of mortality (42). For
these reasons, the presence of abdominal adiposity, which
was not measured in the current study, may have influenced
our results. Overt or latent hyperthyroidism associated with
a low body weight might also increase blood pressure. Fur-
ther epidemiological investigations are thus needed.
The strengths of this study include its prospective cohort
design and the collection of information on potential con-
founders for hypertension at baseline and adjusted for in the
analysis to the extent possible. In addition, previous studies
have suggested that BP, especially SBP, increases with in-
creasing age (43). However, we completely eliminated this
age-derived bias because of the nature of the age-specific
cohort.
This study is associated with several limitations. First, we
did not evaluate information regarding the amount of daily
sodium intake associated with hypertension (44, 45), which
might have caused residual confounding. Although we con-
trolled for major lifestyle issues, family history of hyperten-
sion and clinical risk factors for hypertension, our inferences
may include overestimation of physique-blood pressure as-
sociations. Second, of the 1,667 eligible participants, 664
(39.8%) were lost to follow-up due to death, relocation or
missing the secondary health check-up. This could result in
some selection bias. However, the BMI, SBP and DBP val-
ues at baseline did not differ between the repeat visitors and
non-repeat visitors. Therefore, such bias is expected to be
minimal in this study.
Conclusion
This age-specific cohort study demonstrated that leanness
or being overweight/obese at age 65 increases the risk of
subsequent hypertension.
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